CL reports support (funding, provision of study materials, medical writing, and article processing charges) from Amgen, Bristol Myers Squibb, Merck Serono, MSD, Novartis, Pierre Fabre, Roche, and Sanofi; consulting fees from Amgen, Bristol Myers Squibb, MSD, Novartis, and Roche; payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing, or educational events from Amgen, Bristol Myers Squibb, Incyte, MSD, Novartis, Pfizer, Pierre Fabre, and Roche; payment for experts' testimony from Amgen, Bristol Myers Squibb, MSD, Novartis, and Roche; support for attending meetings or travel from Bristol Myers Squibb, MSD, Novartis, Pierre Fabre, and Sanofi; and has participated on a data safety monitoring board or advisory board for InflaRX. JD reports payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing, or educational events from Bristol Myers Squibb; and support for attending meetings or travel from Pierre Fabre and Roche. All other authors declare no competing interests.